Medpage Today on MSN5d
Do GLP-1 Agonists Really Need to Be Stopped Before Endoscopy?Continuing GLP-1 receptor agonist medications when undergoing an endoscopic procedure appeared safe in a meta-analysis.
GLP-1 receptor agonists and SGLT2 inhibitors, two classes of medications most commonly prescribed to treat Type 2 diabetes or weight loss, may reduce the risk of heart attack, second strokes and death ...
It can be harder to lose weight after a certain age, which is why GLP-1 medications can be incredibly useful. That's where ...
Following a disappointing earnings showing from Eli Lilly last week, Novo Nordisk’s latest report on the performance of its ...
Sixty-six percent regained a portion of their weight, 23% maintained their weight loss, and only 11% continued to lose weight after discontinuing taking a GLP-1. "This survey is critical to ...
Verywell Health on MSN2d
GLP-1 Drug Shortage Is Over. Why Might These Drugs Soon Be Costlier and Harder to Access?The FDA removed Wegovy, Ozempic, Mounjaro, and Zepbound from its drug shortage list for the first time in two years. The move ...
Viking Therapeutics’ GLP-1 pill candidate for treating obesity showed promise in its latest trial results, the clinical-stage ...
HealthDay on MSN4d
Guidance Issued for Safe Use of GLP-1 RAs in the Perioperative PeriodGLP-1 receptor agonist use in the perioperative period should be based on shared decision-making of patient and care teams ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback